Vital Therapies (VTL) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Vital Therapies Announces Third Quarter Financial Results
November 3, 2016 4:01 PM EDTSAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the third quarter ended September 30, 2016.
Key Recent Developments
Twenty subjects have been enrolled at sites in the United States and Europe in VTL-308, the Companys phase 3 randomized, controlled, open-label trial, designed to evaluate the ELAD System in... MoreInvesco Closed-End Funds Declare Dividends
November 1, 2016 1:16 PM EDTATLANTA, Nov. 1, 2016 /PRNewswire/ -- The Board of Trustees of each of the Invesco closed-end funds listed below today declared the following dividends.
                                                                Â
EX-DATEÂ Â Â Â Â RECORD DATE
11/10/16Â Â Â Â Â Â Â 11/14/16Â Â Â
REINVEST DATE11/30/16
PAYABLE DATE11/30/16
Name of... More
